Bojian was sued by insurance company Humana for illegally promoting drug sales through charitable donations

CompilationTom Lee

For years, U.

In a lawsuit filed in Massachusetts last Friday, Humana stated that Bojian disseminates free samples of drugs to patients, and then through charitable donations, these patients are included in medical insurance and other government insurance plans to improve Sales of its multiple sclerosis drugs Tysabri, Avonex and Tecfidera

Humana stated that Biogen "under the guise of unlimited charitable donations," illegally paid co-payments for patients receiving relevant drug treatments

Humana believes that because Biogen's multiple sclerosis drugs cost between US$50,000 and US$80,000 per year, the co-payments for each patient may be as high as thousands of US dollars, and these co-payments only account for "a small amount of the total cost.

Between 2011 and 2019, Humana stated that it spent more than US$2.

In response, Bojian’s representative stated that the company does not comment on pending litigation

Previously, the U.

Although the violation of this type of promotion has been deemed a serious violation by the government, a Bojian spokesperson said after signing a settlement agreement that the company “disagrees with the government’s view of the facts and believes that the company’s approach is appropriate

At the same time, Humana, who filed the lawsuit, has signed a federal settlement agreement with the charity chronic disease fund and aid fund worth US$4 million and US$2 million, respectively

According to reports, in addition to Bojian, Humana also filed similar lawsuits against Teva and Regeneron

Reference source:

Biogen used charity giving to illegally boost multiple sclerosis drug sales, Humana lawsuit says